AMY-A
Long-acting amylin analog class agonist studied alongside incretin-receptor agonists in metabolic-pathway research.
AMY-A is supplied by Bench Grade Peptides as a lyophilized powder in a sealed, lot-numbered vial, for laboratory research use only — not for human or veterinary use.
Its published Certificate of Analysis (lot 00011/0011, analyzed September 3, 2026) is from AV Analytics, a third-party laboratory, and reports 99.76% purity by HPLC; every published lot is listed on the product's COA page. Vials ship at ambient temperature in protective packaging from Florida (Bench Grade Peptides LLC is registered in Dover, Delaware), with storage notes on the lot's certificate.
Long-acting amylin analog class agonist studied alongside incretin-receptor agonists in metabolic-pathway research.
The primary literature on this compound includes Class-level amylin pharmacology reviews. Lutz, Physiol Behav (2010). Trevaskis et al., Endocrinology (2010). The references below link directly to the published record.
Lots are synthesized in the USA and verified by HPLC; where a lot's Certificate of Analysis is published, it is in the COA library. It is supplied strictly for laboratory research use.
Published research
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a phase 1b trialEnebo LB, et al. Lancet. 2021.PubMed →